HomeComparePMSNF vs GBDC

PMSNF vs GBDC: Dividend Comparison 2026

PMSNF yields 10000.00% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PMSNF wins by $55137509079256496.00M in total portfolio value
10 years
PMSNF
PMSNF
● Live price
10000.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55137509079256512.00M
Annual income
$54,073,795,673,722,890,000,000.00
Full PMSNF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — PMSNF vs GBDC

📍 PMSNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMSNFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PMSNF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PMSNF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PMSNF
Annual income on $10K today (after 15% tax)
$850,000.00/yr
After 10yr DRIP, annual income (after tax)
$45,962,726,322,664,450,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, PMSNF beats the other by $45,962,726,322,664,440,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PMSNF + GBDC for your $10,000?

PMSNF: 50%GBDC: 50%
100% GBDC50/50100% PMSNF
Portfolio after 10yr
$27568754539628264.00M
Annual income
$27,036,897,836,861,450,000,000.00/yr
Blended yield
98.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

PMSNF
No analyst data
Altman Z
-16.2
Piotroski
0/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PMSNF buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMSNFGBDC
Forward yield10000.00%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$55137509079256512.00M$20.78M
Annual income after 10y$54,073,795,673,722,890,000,000.00$16,389,263.41
Total dividends collected$55066727460582336.00M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: PMSNF vs GBDC ($10,000, DRIP)

YearPMSNF PortfolioPMSNF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$1,010,700$1,000,000.00$12,490$1,790.28+$998.2KPMSNF
2$95,539,393$94,457,943.93$16,522$3,157.73+$95.52MPMSNF
3$8,447,007,736$8,344,780,585.66$23,578$5,898.68+$8446.98MPMSNF
4$698,565,746,383$689,527,448,105.17$37,115$11,886.75+$698565.71MPMSNF
5$54,040,711,670,213$53,293,246,321,583.74$66,136$26,423.57+$54040711.60MPMSNF
6$3,910,851,616,519,516$3,853,028,055,032,387.00$137,257$66,491.44+$3910851616.38MPMSNF
7$264,781,167,546,477,440$260,596,556,316,801,570.00$341,734$194,868.54+$264781167546.14MPMSNF
8$16,772,556,223,821,672,000$16,489,240,374,546,942,000.00$1,050,788$685,133.02+$16772556223820.62MPMSNF
9$994,124,678,068,810,000,000$976,178,042,909,320,800,000.00$4,099,314$2,974,971.01+$994124678068806.00MPMSNF
10$55,137,509,079,256,515,000,000$54,073,795,673,722,890,000,000.00$20,775,530$16,389,263.41+$55137509079256496.00MPMSNF

PMSNF vs GBDC: Complete Analysis 2026

PMSNFStock

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. It also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers. In addition, the company offers bioinformatics tools, including Proteome Discoverer for peptide sequence and TMT quantitation; SQuaT,CalDIT, and DIANA for normalized quantitative values and functional annotation at peptide and protein level; FeaST for visualization of data quality, class identifier model, and biomarker candidate lists; and FAT for identification of biological processes and cellular components showing variance. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

Full PMSNF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this PMSNF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PMSNF vs SCHDPMSNF vs JEPIPMSNF vs OPMSNF vs KOPMSNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.